Naproxen
- Product NDC
- 68462-189
- 11-digit product format
- 684620189
- Labeler code
- 68462
- Product ID
- 68462-189_16372549-a419-4920-a200-5128017570ed
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Application
- ANDA078250
- Marketing category
- ANDA
- Marketing start
- 2007-07-01
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078250-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | |
| A078250-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | |
| A078250-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078250-001 | AB |
| A078250-002 | AB |
| A078250-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2007-03-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2007-03-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078250-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2007-03-28 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078250-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078250-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078250-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078250-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078250-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078250-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078250-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078250-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078250-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078250-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078250-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078250-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078250-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078250-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078250-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078250-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078250-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078250-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NAPROXEN | 375 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57Y76R9ATQ | Internal UNII lookup |
| 9TN87S3A3C | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68462-189-01 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 68462-189-05 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68462-189-01 | EA - Each | 68462-189 | d9a21b73-912a-47e2-85b3-2d551da14003 | 1 | 2012-07-24 |
| 68462-189-05 | EA - Each | 68462-189 | d354235e-902c-45a3-8e54-120cabf0bb57 | 1 | 2012-07-24 |
| 68462-189-60 | EA - Each | 68462-189 | 60ef9d1f-a9e5-4029-b0d0-5275c9bbd4f9 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | Proficient Rx LP | 96601d76-50ea-4dc0-b588-d174f8d8bb51 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 078250 ANDA078250 |
| Naproxen | NAPROXEN | Proficient Rx LP | 3e4e5371-d796-47c7-95c1-d99e82a0b282 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 078250 ANDA078250 |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 3e14f839-d1e4-44df-a457-29f005b3e62e | 2020-12-15 | Boxed warning, Warnings, Adverse reactions | 078250 ANDA078250 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68462-189-01 | 68462018901 | 100 TABLET in 1 BOTTLE (68462-189-01) | 100 tablet | 2007-07-01 | 0000-00-00 | No | No | Current |
| 68462-189-05 | 68462018905 | 500 TABLET in 1 BOTTLE (68462-189-05) | 500 tablet | 2007-07-01 | 0000-00-00 | No | No | Current |